Log In
Print this Print this

H5N1 VLP vaccine (Pandemic flu vaccine)

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionPlant-based virus-like particle (VLP) vaccine against H5N1 avian influenza pandemic with cross-protective properties
Molecular Target Influenza antigen
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsPrevent H5N1 avian influenza virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today